OM Pharma Ltd. services

OM Pharma wants to become a global leader in the development of microbial-derived immunotherapeutics. The immunotherapeutic products should help to fight acute and chronic immunological disorders resulting from infections and inflammation. Building on a strong knowledge and heritage, the main R&D stream focuses on two pillars which are to treat or prevent such diseases.

Process development capability is ensured thanks to several pilot scale units dedicated to bacterial growth, purification of active principles, lyophilization and capsule filling. A strong analytical science structure from physicochemical analysis to cell-based assay (potency assays) development allows OM Pharma to deploy a control strategy on our products and meet the highest levels of quality standards.a